Tudor Investment Corp
PRAX icon

Tudor Investment Corp’s Praxis Precision Medicines PRAX Stock Holding History

Tudor Investment Corp’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$731K Buy
+2,183
New +$691K ﹤0.01% 2614
2026
Q1 		– Sell
-16,009
Closed -$4.95M – 4144
2025
Q4 		$4.72M Buy
+16,009
New +$2.98M 0.01% 1189

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Tudor Investment Corp's PRAX Position: Q2 2026 in Review

Tudor Investment Corp opened a new position in Praxis Precision Medicines (PRAX) in Q2 2026: 2,183 shares worth $731K. The stake represents ﹤0.01% of the portfolio and ranks #2614 among its holdings. This is a return to the name: Tudor Investment Corp previously reported a position in PRAX as recently as Q4 2025.

Tudor Investment Corp first reported a position in PRAX in Q4 2025 and has held it in 2 quarters since. The position peaked at $4.72M in Q4 2025. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Tudor Investment Corp held 2,183 shares of Praxis Precision Medicines worth $731K as of Q2 2026.
  • Praxis Precision Medicines was a new Tudor Investment Corp position in Q2 2026.
  • Praxis Precision Medicines made up ﹤0.01% of Tudor Investment Corp's portfolio in Q2 2026, its #2614 holding.
  • Tudor Investment Corp first reported a position in Praxis Precision Medicines in Q4 2025 and has held it in 2 quarters since.
  • Tudor Investment Corp's Praxis Precision Medicines position peaked at $4.72M in Q4 2025.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.